Cellebrite DI Ltd. (CLBT) insider plans sale of 1,045 vested shares - Stock Titan

Cellebrite DI Ltd. (CLBT) insider plans sale of 1,045 vested shares Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type 144 Rhea-AI Filing Summary Cellebrite DI Ltd. insider Marcus Jewell has indicated an intent to sell up to 1,045 ordinary shares of the company’s stock through Morgan Stanley Smith Barney LLC. These shares relate to restricted share units that vested on August 11, 2026 under an S-8 registered compensation plan. In the prior three months, Jewell reported selling 383 ordinary shares on May 12, 2026 for $4,982.83 and 12,658 ordinary shares on May 18, 2026 for $161,656.58. Key Figures Planned shares to be sold: 1,045 shares RSUs vested: 1,045 shares Shares sold May 12, 2026: 383 shares for $4,982.83 +2 more 5 metrics PLANNED SHARES TO BE SOLD 1,045 shares Ordinary shares indicated for sale through Morgan Stanley Smith Barney LLC RSUS VESTED 1,045 shares Restricted share units vested on August 11, 2026 under an S-8 plan SHARES SOLD MAY 12, 2026 383 shares for $4,982.83 Ordinary share sale by Marcus Jewell on May 12, 2026 SHARES SOLD MAY 18, 2026 12,658 shares for $161,656.58 Ordinary share sale by Marcus Jewell on May 18, 2026 INDICATED VALUE OF PLANNED SALE $16,343.8 Associated with 1,045 ordinary shares to be sold Key Terms Form 144, Restricted Share Units, S-8 Registered Plan, ordinary shares 4 terms Form 144 REGULATORY Restricted Share Units FINANCIAL S-8 Registered Plan REGULATORY Ordinary Shares FINANCIAL AI-generated analysis. How Rhea-AI works. Not financial advice. See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google Add on Google Not now AVAILABLE ON EDGAR 08/07/2026 - 07:41 AM ACCEPTED BY SEC EDGAR 08/07/2026 - 07:41 AM Learn about SEC filing dates FAQ What does the Form 144 for CLBT disclose about planned share sales? The Form 144 discloses that Marcus Jewell plans to sell up to 1,045 ordinary shares of Cellebrite DI Ltd. through Morgan Stanley Smith Barney LLC, based on recently vested restricted share units under an S-8 registered compensation plan. How many Cellebrite (CLBT) shares is Marcus Jewell planning to sell? Marcus Jewell has indicated an intent to sell up to 1,045 ordinary shares of Cellebrite DI Ltd. These shares stem from restricted share units that vested on August 11, 2026 under a company compensation plan registered on Form S-8. What recent CLBT share sales by Marcus Jewell are reported? The document reports that Marcus Jewell sold 383 ordinary shares on May 12, 2026 for $4,982.83 and 12,658 ordinary shares on May 18, 2026 for $161,656.58, both involving Cellebrite DI Ltd. ordinary shares with par value NIS 0.00001. What is the source of the Cellebrite (CLBT) shares to be sold by Marcus Jewell? The shares to be sold are tied to restricted share units vested on August 11, 2026 under an issuer S-8 registered compensation plan. These RSUs converted into ordinary shares of Cellebrite DI Ltd. with a par value of NIS 0.00001. Which broker is handling Marcus Jewell’s planned CLBT share sale? The planned sale of up to 1,045 Cellebrite ordinary shares by Marcus Jewell is listed through Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza. This firm appears as the broker for the proposed transaction on Nasdaq. ⛶ Fullscreen Source: View Original Filing on SEC EDGAR